14Indexed trials
mesh condition
Nerve Degeneration
Intelligence
Nerve Degeneration intelligence: 14 indexed trials, 8 recruiting studies, 14 sponsors across 12 countries.
8Recruiting
14Sponsors
12Countries
Leading sponsors
Cambridge University Hospitals NHS Foundation Trust11 recruiting
Cedars-Sinai Medical Center11 recruiting
Cerevance Beta, Inc.10 recruiting
Ente Ospedaliero Ospedali Galliera10 recruiting
Invicro10 recruiting
MD Stem Cells11 recruiting
Michal Schnaider Beeri, Ph.D.11 recruiting
Monash University11 recruiting
PTC Therapeutics10 recruiting
University of Alabama at Birmingham11 recruiting
University of Cagliari11 recruiting
University of Colorado, Denver10 recruiting
Geographic activity
United States9trials
Italy3trials
United Kingdom2trials
Japan1trials
Poland1trials
Australia1trials
Sweden1trials
Switzerland1trials
United Arab Emirates1trials
Spain1trials
Canada1trials
France1trials
Leading interventions
Active music therapy1trials
Alpha-Linolenic Acid (2.6 g/day)1trials
CVN424 150 mg1trials
Deferiprone1trials
HV-PDAE: High Volume Partnered Dance Aerobic Exercise1trials
HV-WALK: High Volume Walking1trials
Intravenous and Intranasal BMSC1trials
MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise1trials
MV-WALK: Moderate Volume Walking1trials
Palliative Care1trials
Passive music therapy1trials
Placebo Control Group1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.